Evidence map›Paper›PMID 33931975›Full record

ReviewClinical and translational medicine2021

Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.

Cody Slater, Qi Wang

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Reduction in hippocampal cholinergic neurostimulating peptide enhances memory impairment in AppAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. The Role of Neuroglia in Cognitive Longevity.Neurochemical research · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Mechanism and Applications of Vagus Nerve Stimulation.Current issues in molecular biology · 2025
    Review
  13. Article
  14. Review
  15. Neuroglia in cognitive reserve.Molecular psychiatry · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cody SlaterDepartment of Biomedical Engineering, Columbia University, New York, New York, USA.ORCID 0000-0002-6388-8233
Qi WangDepartment of Biomedical Engineering, Columbia University, New York, New York, USA.ORCID 0000-0001-8656-1439
Columbia University · US

Funding

The role of the locus coeruleus in mediating pupil-linked arousalR01MH112267 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI WANG, QI · 2017 to 2021
$2.0M
The Brief Research in Aging and Interdisciplinary NeurosciencesT35AG044303 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sachin Agarwal, Jennifer Jaie Manly · 2013 to 2026
$1.9M
Cholinergic contribution to pupil-linked arousalR21MH125107 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI WANG, QI · 2021 to 2022
$446k
NIA NIH HHS T35 AG044303NIMH NIH HHS R01 MH112267NIMH NIH HHS R21 MH125107
6 · The paper itself

Abstract

Alzheimer's disease (AD) poses a significant global health concern over the next several decades. Multiple hypotheses have been put forth that attempt to explain the underlying pathophysiology of AD. Many of these are briefly reviewed here, but to-date no disease-altering therapy has been achieved. Despite this, recent work expanding on the role of noradrenergic system dysfunction in both the pathogenesis and symptomatic exacerbation of AD has shown promise. The role norepinephrine (NE) plays in AD remains complicated but pre-tangle tau has consistently been shown to arise in the locus coeruleus (LC) of patients with AD decades before symptom onset. The current research reviewed here indicates NE can facilitate neuroprotective and memory-enhancing effects through β adrenergic receptors, while α

Indexed as

Electric Stimulation TherapyAdrenergic NeuronsAlzheimer DiseaseAnimalsCholinergic NeuronsHumansNorepinephrineReceptors, Adrenergic, alpha-2Receptors, Adrenergic, betaNorepinephrineReceptors, Adrenergic, alpha-2Receptors, Adrenergic, betaAlzheimer's diseaseelectroceuticalsneural stimulationthe locus coeruleus - norepinephrine (LC-NE) system

Identifiers

PMID33931975
PMCPMC8087948
OpenAlexW3157668755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.